Myomo (MYO) Shares Outstanding (2016 - 2025)
Myomo's (MYO) quarterly Shares Outstanding (Entity) came in at $38.4 million in Q3 2025, up 1.27% on a YoY basis from $38.0 million in Q3 2024, and up 1.73% quarter-over-quarter from $37.8 million in Q2 2025.
Analysis
Myomo (MYO) Shares Outstanding (2016 - 2025) Analysis & Trends
Myomo (MYO) has reported Shares Outstanding (Entity) for 10 consecutive years, with $38.4 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Shares Outstanding (Entity) rose 1.27% year-over-year to $38.4 million; the trailing twelve-month figure through Sep 2025 stood at $38.4 million (up 1.27% YoY), and the FY2024 full-year result was $34.4 million, up 26.69% from the prior year.
- Shares Outstanding (Entity) grew to $38.4 million in Q3 2025 per MYO's latest filing, from $37.8 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $38.4 million in Q3 2025 and bottomed at $5.6 million in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $21.8 million across 5 years, with a median of $27.1 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) soared 400.02% in 2023, then dropped 6.3% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $6.9 million in 2021, then advanced by 12.82% to $7.8 million in 2022, then surged by 250.1% to $27.1 million in 2023, then rose by 26.69% to $34.4 million in 2024, then gained by 11.8% to $38.4 million in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $38.4 million, $37.8 million, and $34.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | 42.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 42.17 Mn |
| Sep 30, 2025 | 42.17 Mn |
| Jun 30, 2025 | 41.58 Mn |
| Mar 31, 2025 | 41.45 Mn |
| Dec 31, 2024 | 37.76 Mn |
| Sep 30, 2024 | 37.95 Mn |
| Jun 30, 2024 | 37.37 Mn |
| Mar 31, 2024 | 36.75 Mn |
| Dec 31, 2023 | 29.50 Mn |
| Sep 30, 2023 | 35.27 Mn |
| Jun 30, 2023 | 27.99 Mn |
| Mar 31, 2023 | 24.20 Mn |
| Dec 31, 2022 | 7.05 Mn |
| Sep 30, 2022 | 7.06 Mn |
| Jun 30, 2022 | 6.92 Mn |
| Mar 31, 2022 | 6.89 Mn |
| Dec 31, 2021 | 5.83 Mn |
| Sep 30, 2021 | 5.68 Mn |
| Jun 30, 2021 | 5.64 Mn |
| Mar 31, 2021 | 5.19 Mn |